Unknown OBSERVATIONAL NCT06281262

Selected Immunological Indicators and Microbiota in Patients With Premature Birth and Preeclampsia (PRIME)

The Role of Selected Immunological Indicators and Microbiota in Patients Experiencing Premature Birth and Preeclampsia

Sponsor: Charles University, Czech Republic

Interventions Peripheral blood collection Swab sample collection

Updated 5 times since 2024 Last updated: Feb 29, 2024 Started: Jun 30, 2023 Primary completion: Mar 30, 2025 Completion: Mar 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Preeclampsia and Preterm Birth and is currently ongoing. Charles University, Czech Republic leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Mar 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Mar 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting
Mar 2024 — Apr 2024 [monthly]

Recruiting

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charles University, Czech Republic
General University Hospital, Prague
Institute of Hematology and Blood Transfusion, Czech Republic

Data source: General University Hospital, Prague

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prague, Czechia